Global Hypercholesterolemia Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 118 pages | ID: GDCBD8AE950EN
GlobalInfoResearch

Abstracts

Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases. Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity. In case of genetic factors, the number of copies of the gene determines the severity of the disease. People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.

Scope of the Report:

The global Hypercholesterolemia Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hypercholesterolemia Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Hypercholesterolemia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hypercholesterolemia Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

• CymaBay Therapeutics Inc
• Daewoong Co Ltd
• Gemphire Therapeutics Inc
• LipimetiX Development Inc
• Regeneron Pharmaceuticals Inc
• RegenxBio Inc
• The Medicines Company

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• AEM-2802
• AEM-2814
• Alirocumab
• Evinacumab
• Others

Market Segment by Applications, can be divided into

• Clinic
• Hospital
• Others

Contents

1 HYPERCHOLESTEROLEMIA TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Hypercholesterolemia Treatment
1.2 Classification of Hypercholesterolemia Treatment by Types
  1.2.1 Global Hypercholesterolemia Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Hypercholesterolemia Treatment Revenue Market Share by Types in 2017
  1.2.3 AEM-2802
  1.2.4 AEM-2814
  1.2.5 Alirocumab
  1.2.6 Evinacumab
  1.2.7 Others
1.3 Global Hypercholesterolemia Treatment Market by Application
  1.3.1 Global Hypercholesterolemia Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Global Hypercholesterolemia Treatment Market by Regions
  1.4.1 Global Hypercholesterolemia Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Hypercholesterolemia Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Hypercholesterolemia Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hypercholesterolemia Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Hypercholesterolemia Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hypercholesterolemia Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Hypercholesterolemia Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 CymaBay Therapeutics Inc
  2.1.1 Business Overview
  2.1.2 Hypercholesterolemia Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Daewoong Co Ltd
  2.2.1 Business Overview
  2.2.2 Hypercholesterolemia Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Daewoong Co Ltd Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Gemphire Therapeutics Inc
  2.3.1 Business Overview
  2.3.2 Hypercholesterolemia Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 LipimetiX Development Inc
  2.4.1 Business Overview
  2.4.2 Hypercholesterolemia Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 LipimetiX Development Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Regeneron Pharmaceuticals Inc
  2.5.1 Business Overview
  2.5.2 Hypercholesterolemia Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 RegenxBio Inc
  2.6.1 Business Overview
  2.6.2 Hypercholesterolemia Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 RegenxBio Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 The Medicines Company
  2.7.1 Business Overview
  2.7.2 Hypercholesterolemia Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 The Medicines Company Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HYPERCHOLESTEROLEMIA TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Hypercholesterolemia Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Hypercholesterolemia Treatment Players Market Share
  3.2.2 Top 10 Hypercholesterolemia Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL HYPERCHOLESTEROLEMIA TREATMENT MARKET SIZE BY REGIONS

4.1 Global Hypercholesterolemia Treatment Revenue and Market Share by Regions
4.2 North America Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HYPERCHOLESTEROLEMIA TREATMENT REVENUE BY COUNTRIES

5.1 North America Hypercholesterolemia Treatment Revenue by Countries (2013-2018)
5.2 USA Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE HYPERCHOLESTEROLEMIA TREATMENT REVENUE BY COUNTRIES

6.1 Europe Hypercholesterolemia Treatment Revenue by Countries (2013-2018)
6.2 Germany Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
6.4 France Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HYPERCHOLESTEROLEMIA TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Hypercholesterolemia Treatment Revenue by Countries (2013-2018)
7.2 China Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
7.5 India Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HYPERCHOLESTEROLEMIA TREATMENT REVENUE BY COUNTRIES

8.1 South America Hypercholesterolemia Treatment Revenue by Countries (2013-2018)
8.2 Brazil Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HYPERCHOLESTEROLEMIA TREATMENT BY COUNTRIES

9.1 Middle East and Africa Hypercholesterolemia Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL HYPERCHOLESTEROLEMIA TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Hypercholesterolemia Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Hypercholesterolemia Treatment Market Forecast by Type (2018-2023)
10.3 AEM-2802 Revenue Growth Rate (2013-2023)
10.4 AEM-2814 Revenue Growth Rate (2013-2023)
10.5 Alirocumab Revenue Growth Rate (2013-2023)
10.6 Evinacumab Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)

11 GLOBAL HYPERCHOLESTEROLEMIA TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Hypercholesterolemia Treatment Revenue Market Share by Application (2013-2018)
11.2 Hypercholesterolemia Treatment Market Forecast by Application (2018-2023)
11.3 Clinic Revenue Growth (2013-2018)
11.4 Hospital Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)

12 GLOBAL HYPERCHOLESTEROLEMIA TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Hypercholesterolemia Treatment Market Size Forecast (2018-2023)
12.2 Global Hypercholesterolemia Treatment Market Forecast by Regions (2018-2023)
12.3 North America Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
12.6 South America Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hypercholesterolemia Treatment Picture
Table Product Specifications of Hypercholesterolemia Treatment
Table Global Hypercholesterolemia Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Hypercholesterolemia Treatment Revenue Market Share by Types in 2017
Figure AEM-2802 Picture
Figure AEM-2814 Picture
Figure Alirocumab Picture
Figure Evinacumab Picture
Figure Others Picture
Table Global Hypercholesterolemia Treatment Revenue (Million USD) by Application (2013-2023)
Figure Hypercholesterolemia Treatment Revenue Market Share by Applications in 2017
Figure Clinic Picture
Figure Hospital Picture
Figure Others Picture
Table Global Market Hypercholesterolemia Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table CymaBay Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table CymaBay Therapeutics Inc Hypercholesterolemia Treatment Type and Applications
Table CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Daewoong Co Ltd Basic Information, Manufacturing Base and Competitors
Table Daewoong Co Ltd Hypercholesterolemia Treatment Type and Applications
Table Daewoong Co Ltd Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Gemphire Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Gemphire Therapeutics Inc Hypercholesterolemia Treatment Type and Applications
Table Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table LipimetiX Development Inc Basic Information, Manufacturing Base and Competitors
Table LipimetiX Development Inc Hypercholesterolemia Treatment Type and Applications
Table LipimetiX Development Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Type and Applications
Table Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table RegenxBio Inc Basic Information, Manufacturing Base and Competitors
Table RegenxBio Inc Hypercholesterolemia Treatment Type and Applications
Table RegenxBio Inc Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table The Medicines Company Basic Information, Manufacturing Base and Competitors
Table The Medicines Company Hypercholesterolemia Treatment Type and Applications
Table The Medicines Company Hypercholesterolemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hypercholesterolemia Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Hypercholesterolemia Treatment Revenue Share by Players (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue Share by Players in 2016
Figure Global Hypercholesterolemia Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Hypercholesterolemia Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Hypercholesterolemia Treatment Revenue Market Share in 2017
Figure Global Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Hypercholesterolemia Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Hypercholesterolemia Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue Market Share by Regions in 2017
Figure North America Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure South America Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Table North America Hypercholesterolemia Treatment Revenue by Countries (2013-2018)
Table North America Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Hypercholesterolemia Treatment Revenue Market Share by Countries in 2017
Figure USA Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Table Europe Hypercholesterolemia Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Hypercholesterolemia Treatment Revenue Market Share by Countries in 2017
Figure Germany Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure UK Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure France Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hypercholesterolemia Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Hypercholesterolemia Treatment Revenue Market Share by Countries in 2017
Figure China Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure India Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Table South America Hypercholesterolemia Treatment Revenue by Countries (2013-2018)
Table South America Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Hypercholesterolemia Treatment Revenue Market Share by Countries in 2017
Figure Brazil Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hypercholesterolemia Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hypercholesterolemia Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hypercholesterolemia Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Hypercholesterolemia Treatment Revenue and Growth Rate (2013-2018)
Table Global Hypercholesterolemia Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Hypercholesterolemia Treatment Revenue Share by Type (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue Share by Type (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue Share by Type in 2017
Table Global Hypercholesterolemia Treatment Revenue Forecast by Type (2018-2023)
Figure Global Hypercholesterolemia Treatment Market Share Forecast by Type (2018-2023)
Figure Global AEM-2802 Revenue Growth Rate (2013-2018)
Figure Global AEM-2814 Revenue Growth Rate (2013-2018)
Figure Global Alirocumab Revenue Growth Rate (2013-2018)
Figure Global Evinacumab Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Hypercholesterolemia Treatment Revenue by Application (2013-2018)
Table Global Hypercholesterolemia Treatment Revenue Share by Application (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue Share by Application (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue Share by Application in 2017
Table Global Hypercholesterolemia Treatment Revenue Forecast by Application (2018-2023)
Figure Global Hypercholesterolemia Treatment Market Share Forecast by Application (2018-2023)
Figure Global Clinic Revenue Growth Rate (2013-2018)
Figure Global Hospital Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Hypercholesterolemia Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Hypercholesterolemia Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Hypercholesterolemia Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
Figure Europe Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
Figure South America Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Hypercholesterolemia Treatment Revenue Market Forecast (2018-2023)